Loading…
Tyra Biosciences, Inc. is projected to rise to $42.34 by 2027, a +28% move from its current price of $33.17. TYRA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $32.39 | $33.19 | $34.01 | +0.06% |
| May 30 | $32.08 | $33.21 | $34.38 | +0.12% |
| May 31 | $31.85 | $33.23 | $34.67 | +0.18% |
| Jun 1 | $31.66 | $33.25 | $34.92 | +0.24% |
| Jun 2 | $31.50 | $33.27 | $35.14 | +0.30% |
| Jun 3 | $31.35 | $33.29 | $35.34 | +0.36% |
| Jun 4 | $31.22 | $33.31 | $35.53 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.22 | $33.31 | $35.53 | +0.42% |
| Week 2 | $30.53 | $33.45 | $36.65 | +0.84% |
| Week 3 | $30.03 | $33.59 | $37.57 | +1.26% |
| Week 4 | $29.64 | $33.73 | $38.39 | +1.69% |
| Week 5 | $29.31 | $33.87 | $39.14 | +2.12% |
| Week 6 | $29.03 | $34.01 | $39.85 | +2.54% |
| Week 7 | $28.78 | $34.16 | $40.53 | +2.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tyra Biosciences, Inc. is a clinical-stage biotechnology company that develops precision medicines for FGFR biology in the United States. It offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.
Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, TYRA-200 for intrahepatic cholangiocarcinoma, and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc.
was incorporated in 2018 and is headquartered in Carlsbad, California.
TYRA trades in the Healthcare sector under the TYRA ticker. The stock currently costs $32.47 per share and carries a market capitalization of $1.93B. Its rank is 2024. The forecast outlines a path of potential upside through the coming years, with a neutral stance in 2026 and bullish sentiment building thereafter, culminating in strong long-term averages and sizable ROIs by 2030 and beyond.
A major floor 15.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.1% away) — a key level to hold.
The nearest ceiling, 13.3% above — a clean break opens room to run.
A major ceiling 19.4% above — clearing it would confirm fresh momentum.
Key TYRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TYRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.13 | Buy | $33.42 | Sell |
| MA 10 | $34.48 | Sell | $33.89 | Sell |
| MA 20 | $34.32 | Sell | $34.41 | Sell |
| MA 50 | $35.79 | Sell | $34.55 | Sell |
| MA 100 | $33.56 | Sell | $32.21 | Buy |
| MA 200 | $24.83 | Buy | $27.26 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.40 | Neutral |
| Stoch RSI (14) | 21.84 | Neutral |
| CCI (20) | -77.12 | Neutral |
| Williams %R (14) | -84.68 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -3.35 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 15.32 | Buy |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | -1.86 | Sell |
| Ultimate (7,14,28) | 30.60 | Neutral |
| Momentum (10) | -1.70 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 32.41 | Buy |
| ADX (14) | 12.23 | Neutral |
| ATR (14) | 0.85 | Info |
The 30-day technical picture shows bullish sentiment, with a RSI14 of 40 and a SMA50 of $35.91 versus a SMA200 of $24.60. Immediate support is at $32.47 and resistance at $37.59, framing a 30-day range from $27.56 to $38.26. The stock’s annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $26.29 | $33.17 | $43.50 | 0% | Neutral | |
| $33.92 | $42.34 | $55.78 | +28% | Bullish | |
| $36.93 | $47.22 | $64.26 | +42% | Bullish | |
| $40.29 | $52.56 | $73.39 | +58% | Bullish | |
| $50.80 | $67.44 | $96.25 | +103% | Bullish | |
| $58.86 | $79.42 | $115.53 | +139% | Bullish | |
| $67.27 | $92.15 | $136.38 | +178% | Bullish | |
| $74.13 | $102.99 | $154.83 | +210% | Bullish | |
| $73.44 | $103.40 | $157.71 | +212% | Bullish | |
| $79.99 | $114.08 | $176.35 | +244% | Bullish | |
| $133.69 | $202.03 | $330.51 | +509% | Bullish | |
| $224.57 | $374.47 | $665.76 | +10.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $26.29 | $33.17 | $39.04 | +0.00% |
| June 2026 | $29.54 | $34.61 | $41.46 | +4.35% |
| July 2026 | $29.67 | $35.03 | $42.47 | +1.21% |
| August 2026 | $29.12 | $34.58 | $42.31 | -1.29% |
| September 2026 | $29.38 | $35.05 | $43.22 | +1.38% |
| October 2026 | $29.76 | $35.67 | $44.28 | +1.75% |
| November 2026 | $29.08 | $35.00 | $43.71 | -1.88% |
| December 2026 | $28.67 | $34.63 | $43.50 | -1.06% |
Click any year to see its month-by-month TYRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TYRA to range from $26.29 to $43.50 through 2026. The $33.17 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TYRA price prediction for 2027 points to an average of $42.34 (low $33.92, high $55.78) — a potential gain of +28% on today's $33.17. Momentum favours further upside here.
In 2028, TYRA is projected to trade between $36.93 and $64.26, averaging $47.22 — a potential gain of +42% from today's $33.17. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Tyra Biosciences, Inc.'s 2029 outlook centres on $52.56, within a $40.29 to $73.39 range. That is up +11% on the projected 2028 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2030, TYRA could reach as high as $96.25, with a base case around $67.44 and support toward $50.80 — roughly +103% from $33.17. Buyers look set to stay in control over this stretch.
Expect TYRA to range from $58.86 to $115.53 through 2031. The $79.42 average target implies a +139% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The TYRA price prediction for 2032 points to an average of $92.15 (low $67.27, high $136.38) — a potential gain of +178% on today's $33.17. Buyers look set to stay in control over this stretch.
In 2033, TYRA is projected to trade between $74.13 and $154.83, averaging $102.99 — a potential gain of +210% from today's $33.17. That is up +12% on the projected 2032 average. Momentum favours further upside here.
Tyra Biosciences, Inc.'s 2034 outlook centres on $103.40, within a $73.44 to $157.71 range. That is up 0% on the projected 2033 average. That marks a +212% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TYRA could reach as high as $176.35, with a base case around $114.08 and support toward $79.99 — roughly +244% from $33.17. Momentum favours further upside here.
Expect TYRA to range from $133.69 to $330.51 through 2040. The $202.03 average target implies a +509% move from current prices. That is up +77% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TYRA price prediction for 2050 points to an average of $374.47 (low $224.57, high $665.76) — a potential gain of +10.3x on today's $33.17. Momentum favours further upside here.
Investing $1,000 in TYRA today (≈ 30.147724 TYRA) could be worth
$11,289.47
+$10,289.47 (+1029%) by 2050 · US Dollar
Based on the average projected TYRA price of $374.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TYRAwould be worth at today's price.
$1,000 invested in TYRA on May 27, 2025 (≈ 113.378689 TYRA) would be worth
$3,760.77
+$2,760.77 (+276.1%) today · 3.76× · US Dollar
Based on a TYRA entry price of $8.82 vs. today's $33.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.4 | $993.11 | -0.7% |
| 1 month ago | $36.92 | $898.43 | -10.2% |
| 3 months ago | $33.18 | $999.7 | -0.0% |
| 6 months ago | $22.56 | $1,470.3 | +47.0% |
| 1 year ago | $8.82 | $3,760.77 | +276.1% |
| All time (4.7y) ago | $26 | $1,275.77 | +27.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TYRA forecast.
Our base-case forecast reaches $66.00 around 2030.
Implied market cap at $66.00: $3.93B
The multi-year forecast shows a growing price path with rising averages and strong upside. In 2027 the average is $41.21, followed by $64.44 in 2030 with an ROI of 98.5% and bullish sentiment. By 2040 the average rises to $186.81 (ROI 475.4%), and by 2050 the average is $344.56 (ROI 961.2%), with a max of $92.29 in 2030, $307.27 in 2040, and $616.47 in 2050.
The forecast maintains bullish sentiment across the horizon, but notes that these are estimates and subject to uncertainty. The analysis also reflects an elevated volatility environment, at 50% annualized.
Tap a question to reveal the answer.
In 2030, the forecast shows a min of $48.38, an avg of $64.44, and a max of $92.29 with an estimated ROI of 98.5% and bullish sentiment.
Yes. The forecast is neutral for 2026 (avg $32.47) and bullish from 2027 onward, with 2027 avg $41.21, 2028 $45.36, 2029 $50.31, and rising through 2030 ($64.44) and beyond.
Yes. The forecast shows higher-price opportunities, with a max of $110.01 in 2031 and $130.12 in 2032.
Current price is $32.47; market cap is $1.93B.
Sentiment is BULLISH; RSI14 is 40; SMA50 is $35.91; SMA200 is $24.60; support is $32.47 and resistance is $37.59. The 30-day range runs from $27.56 to $38.26, and annualized volatility is 50%.
Tyra Biosciences, Inc. Community Discussion
0Share your Tyra Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.